% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • chimakot chimakot Jun 11, 2013 11:45 AM Flag

    A double digit stock price will happen sooner than later.

    I'm holding tight and will continue to buy more shares with the move higher. This stock has the potential to be a 5 bagger at THESE levels. GL, now Let's Ride!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 9 month tox data clears the way for a run at $10++ and either a EU partnership or a buy-out

      Their drug discovery platform is also going to be a value driver when they start to put drugs into P1 development.
      These antibiotics are all going to get fast tracked under the new FDA trial guidelines.

      their is no doubt that a bigger player is going to buy TSRX for a big fat premo.

      • 1 Reply to coldpizza22
      • 9 month toxicity data already in, bud:

        The recent results of a 9 month toxicity study showing that tedizolid does not produce optic or peripheral neuropathies at concentrations of up to 6-fold its therapeutic exposure (maximum dose tested) suggests that tedizolid may be suitable for the treatment of complicated bacteremia and other diseases requiring long term dosing. By contrast, linezolid at 1x its therapeutic exposure shows neuropathies within 3 months.

        Sentiment: Strong Buy

    • Maybe I need to go outside ... the pps ALWAYS pops when I'm away!

      Just waiting for some sun and then I'm outta here!

      I think we're in a "no wake zone" on the pond today ... pretty quiet!